Pouya Safarzadeh Kozani Selected Research

Hematologic Neoplasms (Hematological Malignancy)

6/2022	CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?
1/2022	CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil.
1/2022	Recent Advances in Solid Tumor CAR-T Cell Therapy: Driving Tumor Cells From Hero to Zero?
1/2021	Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward.
1/2021	Strategies for Dodging the Obstacles in CAR T Cell Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pouya Safarzadeh Kozani Research Topics

Disease

12	Neoplasms (Cancer) 01/2023 - 10/2020
5	Hematologic Neoplasms (Hematological Malignancy) 06/2022 - 01/2021
5	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2021
4	Multiple Myeloma 01/2023 - 01/2021
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 01/2021
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2021 - 01/2021
2	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 10/2021 - 01/2021
1	Leukemia 01/2023
1	Ovarian Neoplasms (Ovarian Cancer) 01/2023
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2023
1	Esophageal Squamous Cell Carcinoma 09/2022
1	Neoplasm Metastasis (Metastasis) 06/2022
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Lymphoma (Lymphomas) 01/2021
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2021
1	Cytokine Release Syndrome 01/2021

Drug/Important Bio-Agent (IBA)

11	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2021
7	AntigensIBA 01/2023 - 10/2020
2	Neoplasm Antigens (Tumor Antigens)IBA 01/2022 - 07/2021
2	Artificial ReceptorsIBA 01/2021 - 10/2020
1	mirvetuximab soravtansineIBA 01/2023
1	taxaneIBA 01/2023
1	Bevacizumab (Avastin)FDA Link 01/2023
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2023
1	PlatinumIBA 01/2023
1	SilverIBA 01/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023
1	HLA-A*02:01 antigenIBA 09/2022
1	Peptides (Polypeptides)IBA 09/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2022
1	SugarsIBA 06/2022
1	Proteins (Proteins, Gene)FDA Link 06/2022
1	GlycosyltransferasesIBA 06/2022
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	human ERBB2 proteinIBA 01/2022

Therapy/Procedure

11	Therapeutics 01/2023 - 10/2020
2	Immunotherapy 01/2023 - 04/2022
1	Drug Therapy (Chemotherapy) 01/2023
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2022